1. Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program. (June 2014) Authors: Bigal, Marcelo E; Escandon, Rafael; Bronson, Michele; Walter, Sarah; Sudworth, Maria; Huggins, John P; Garzone, Pamela Journal: Cephalalgia Issue: Volume 34:Number 7(2014) Page Start: 483 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗